Science Current Events | Science News | Brightsurf.com
 

Building a better Rift Valley fever vaccine

June 28, 2012

University of Texas Medical Branch researchers have significantly improved an existing experimental vaccine for Rift Valley fever virus, making possible the development of a more effective defense against the dangerous mosquito-borne pathogen.

The African virus causes fever in humans, inflicting liver damage, blindness, encephalitis and even death on a small percentage of those it infects. It also attacks cattle, sheep and goats, producing high mortality rates in newborn animals and causing spontaneous abortions in nearly all infected pregnant sheep.

In 2000, outbreaks of Rift Valley fever in Yemen and Saudi Arabia showed that the virus could expand beyond its original range. With this and the rapid North American spread of West Nile virus in mind, infectious-disease experts have long feared that Rift Valley fever virus might come to the United States or Europe, causing major human suffering and devastating the livestock industry in affected areas.

"If Rift Valley fever virus were introduced to the U.S. or Europe, it would be a very scary situation," said UTMB assistant professor and Sealy Center for Vaccine Development member Tetsuro Ikegami, lead author of a paper on the vaccine work now online in the Journal of Virology. "To be ready to respond, we want a vaccine that can raise immune response very quickly in large animals and health workers. We also want a vaccine that will allow us to differentiate between infected and vaccinated animals."

Ikegami's first requirement - quick response - dictated the use of a so-called "live attenuated vaccine." A live attenuated vaccine is a strain of virus that has been weakened to harmlessness, but still has the ability to reproduce and provoke a robust immune response. Such vaccines often require only a single injection, increasing speed and convenience of administration.

A live attenuated vaccine for Rift Valley Fever virus already exists, a strain called MP-12. MP-12 produces a strong immune response in humans and livestock, but human safety trials of the vaccine have never been completed. Practical application of MP-12 faces other obstacles as well. For one thing, researchers worry that the vaccine retains a small amount of residual virulence. For another, they're concerned that the antibodies MP-12 evokes are identical to those produced in response to infection by full-strength Rift Valley fever virus. In an outbreak, public health officials would be unable to tell animals vaccinated with MP-12 from naturally infected ones, making it impossible for them to map the epidemic's spread and respond effectively.

To resolve these issues, Ikegami and his colleagues went to work on MP-12's genome, focusing on a segment designated NSs. When a Rift Valley fever virus enters a cell, NSs produces proteins that function like saboteurs. They attack two of the cell's key defense systems: the genetic mechanism that generates the antiviral protein interferon beta, and a protein called PKR, which suppresses viral protein production.

"We removed the NSs gene because we thought it would attenuate MP-12 further, and it would make it easy to differentiate infected from vaccinated animals - MP-12 without NSs wouldn't produce any anti-NSs antibody, thus giving a different antibody response from wild-type Rift Valley fever virus," Ikegami said.

Experiments with mice exposed to Rift Valley fever virus in UTMB's Robert E. Shope, MD Biosafety Level 4 Laboratory confirmed that the NSs-less strain remained a highly effective vaccine. But Ikegami was not satisfied.

"The neutralizing antibody response was slightly decreased, and I thought we could do better if we retained some of the function of the NSs," he said. To do this, the team introduced a gene for a "dominant negative PKR" - a molecule that would interfere with the cell-defending PKR protein, allowing the vaccine virus to multiply more freely. When they tested the new vaccine strain in mice, they found that it actually protected the animals better than MP-12.

"We got really good efficacy in mice, and we're hoping it will translate well to large animals," Ikegami said. "This has been a very successful project, with some great teamwork and major contributions from two postdocs, Olga Lihoradova and Birte Kalveram."

University of Texas Medical Branch at Galveston


Related Rift Valley Fever Current Events and Rift Valley Fever News Articles


Scottish university scientist behind successful rapid-detection Ebola test
A rapid-detection Ebola test developed by international scientists including a University of Stirling, Scotland virologist has been deployed following a highly effective pilot project.

Damming and damning hemorrhagic diseases
A potential mechanism to combat diseases caused by haemorrhagic fever viruses has been discovered by researchers at the University of Montreal's Department of Biochemistry and Molecular Medicine.

Sierra Leone samples: Ebola evidence in West Africa in 2006
Analysis of clinical samples from suspected Lassa fever cases in Sierra Leone showed that about two-thirds of the patients had been exposed to other emerging diseases, and nearly nine percent tested positive for Ebola virus.

Newly identified natural protein blocks HIV, other deadly viruses
A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated "priority pathogens" for national biosecurity purposes by the National Institute of Allergy and Infectious Disease.

Turmeric Spices Up Virus Study
The popular spice turmeric packs more than just flavor - it shows promise in fighting devastating viruses, Mason researchers recently discovered.

Researchers find 'broad spectrum' antiviral that fights multitude of viruses
Viruses are insidious creatures. They differ from each other in many ways, and they can mutate - at times seemingly at will, as with HIV - to resist a host of weapons fired at them. Complicating matters further is that new viruses are constantly emerging.

Scientists uncover secrets of potential bioterror virus
Researchers at the University of Texas Medical Branch at Galveston have discovered a key tactic that the Rift Valley fever virus uses to disarm the defenses of infected cells.

Researchers examine role of climate change in disease spread
Ever since scientists first proposed that our planet might be experiencing widespread climate change, concerns have been raised about its implications for the spread of arboviruses - viruses carried by arthropods such as mosquitoes, midges and ticks.

'Deadly dozen' reports diseases worsened by climate change
Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies.

NASA technology helps predict and prevent future pandemic outbreaks
With the help of 14 satellites currently in orbit and the National Aeronautics and Space Administration's (NASA) Applied Sciences Program, scientists have been able to observe the Earth's environment to help predict and prevent infectious disease outbreaks around the world.
More Rift Valley Fever Current Events and Rift Valley Fever News Articles

Ebola Guide: Infection Control for Viral Hemorrhagic Fevers (VHFs) in the African Health Care Setting (including Lassa Fever, Rift Valley Fever, Ebola, Marburg, Yellow Fever) - Isolation Precautions

Ebola Guide: Infection Control for Viral Hemorrhagic Fevers (VHFs) in the African Health Care Setting (including Lassa Fever, Rift Valley Fever, Ebola, Marburg, Yellow Fever) - Isolation Precautions
by Progressive Management


This vital guide from the CDC and WHO, converted for accurate flowing-text ebook format reproduction, provides critically important information about procedures for preventing the transmission of VHFs. In Africa, viral haemorrhagic fevers (VHFs) include Lassa fever, Rift Valley fever, Marburg and Ebola haemorrhagic fevers, Crimean-Congo haemorrhagic fever (CCHF) and yellow fever. Humans initially contract an infection with a haemorrhagic fever virus through exposure to rodents or insects (for Ebola and Marburg VHFs, the natural reservoir is unknown). Person-to-person transmission of Lassa, Ebola, Marburg and CCHF viruses can occur through direct contact with VHF-infected material.

This manual describes a system for using VHF Isolation Precautions to reduce the risk of...

Valley Fever Epidemic

Valley Fever Epidemic
by David Filip (Author), Sharon Filip (Author)


Valley Fever Epidemic is the first and only comprehensive, complete, and up-to-date book written for the lay person on the subject of coccidioidomycosis, commonly known as Valley Fever. It is easy to read and understand and features detailed in-depth information on the disease¿s symptoms, diagnosis, testing, drugs and treatment, risk factors, and more. This book also includes maps and statistics, frequently asked questions, what you need to know before you see a doctor, how to help boost your immune system, and stories that people with Valley Fever sent to the authors at www.valleyfeversurvivor.com. The chapter on how Valley Fever affects animals contains stories from pet owners as well. In addition, this book has a medical glossary of over 465 words with definitions that translate...

First Aid for the Usmle Step 1, 2016

First Aid for the Usmle Step 1, 2016
by Tao Le (Author), Vikas Bhushan (Author)


THE “BIBLE” FOR USMLE STEP 1 PREP―AND THE ULTIMATE TOOL FOR ORGANIZING YOUR STUDY!This annually updated review delivers a comprehensive collection of high-yield facts and mnemonics that pinpoint exactly what students need to know to pass the exam. Co-authored by medical students who recently took the boards, it provides a complete framework to help students prepare for the most stressful exam of their careers.1,250+ must-know topics provide a complete framework for your Step 1 preparationTest-taking advice with focus on high-efficiency studyingUpdated in all subject areas based on feedback from thousands of studentsExtensive faculty review process with nationally known USMLE instructors1,000+ color photos and diagrams help you visualize high-yield conceptsExpanded guide to top-rated...

The Hot Zone: The Terrifying True Story of the Origins of the Ebola Virus

The Hot Zone: The Terrifying True Story of the Origins of the Ebola Virus
by Richard Preston (Author)


The bestselling landmark account of the first emergence of the Ebola virus. A highly infectious, deadly virus from the central African rain forest suddenly appears in the suburbs of Washington, D.C. There is no cure. In a few days 90 percent of its victims are dead. A secret military SWAT team of soldiers and scientists is mobilized to stop the outbreak of this exotic "hot" virus. The Hot Zone tells this dramatic story, giving a hair-raising account of the appearance of rare and lethal viruses and their "crashes" into the human race. Shocking, frightening, and impossible to ignore, The Hot Zone proves that truth really is scarier than fiction.

  Rift Valley Fever Prediction and Risk Mapping: 2014-2015 Season
by Assaf Anyamba (Author)




  Rift Valley Fever Risk Map Model and Seroprevalence in Selected Wild Ungulates and Camels from Kenya
by Seth C. Britch (Author)




  Rift Valley Fever Antibody in Human Sera Collected after an Outbreak in Domestic Animals in Kenya
by F G Davies (Author)




  Rift Valley Fever Virus: Molecular Biologic Studies of the M Segment RNA(Ribonucleic Acids) for Application in Disease Prevention
by Marc S. Collett (Author)




  RIFT VALLEY FEVER VIRUS ASSAY IN SERUM-FREE HAMSTER KIDNEY MONOLAYERS
by John J. Boyle (Author)




  RIFT VALLEY FEVER VIRUS HEPATITIS LIGHT AND ELECTRON MICROSCOPIC STUDIES IN THE MOUSE
by Malcolm H. McGavran (Author)




© 2016 BrightSurf.com